Novel acyclic adenosine analogs inhibit Epstein-Barr virus replication
about
9-[(2RS)-3-fluoro-2-phosphonylmethoxypropyl] derivatives of purines: a class of highly selective antiretroviral agents in vitro and in vivoEfficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine in various models of herpes simplex virus infection in miceComparative activities of several nucleoside analogs against duck hepatitis B virus in vitroInhibitory effects of selected antiviral compounds on human hepatitis B virus DNA synthesisSusceptibility of human immunodeficiency virus type 1 replication in vitro to acyclic adenosine analogs and synergy of the analogs with 3'-azido-3'-deoxythymidineInhibition of Epstein-Barr virus replication by a benzimidazole L-riboside: novel antiviral mechanism of 5, 6-dichloro-2-(isopropylamino)-1-beta-L-ribofuranosyl-1H-benzimidazole.Efficacy of phosphonylmethoxyalkyl derivatives of adenine in experimental herpes simplex virus and vaccinia virus infections in vivoComparison of two bromovinyl nucleoside analogs, 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil and E-5-(2-bromovinyl)-2'-deoxyuridine, with acyclovir in inhibition of Epstein-Barr virus replication(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replicationA randomized placebo-controlled trial of adefovir dipivoxil in advanced HIV infection: the ADHOC trial.Theodore E. Woodward Award: development of novel, EBV-targeted therapies for EBV-positive tumorsMetabolic pathways for activation of the antiviral agent 9-(2-phosphonylmethoxyethyl)adenine in human lymphoid cellsAdefovir dipivoxil: review of a novel acyclic nucleoside analogue.Identification and functional characterization of Epstein-Barr virus DNA polymerase by in vitro transcription-translation of a cloned geneInhibitory effects of acyclic nucleoside phosphonate analogs, including (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, on Epstein-Barr virus replication.Hsp90 inhibitor 17-DMAG decreases expression of conserved herpesvirus protein kinases and reduces virus production in Epstein-Barr virus-infected cellsEvaluation of novel acyclic nucleoside phosphonates against human and animal gammaherpesviruses revealed an altered metabolism of cyclic prodrugs upon Epstein-Barr virus reactivation in P3HR-1 cellsIn vitro and in vivo inhibition of murine gamma herpesvirus 68 replication by selected antiviral agents.Antiretrovirus activity of a novel class of acyclic pyrimidine nucleoside phosphonatesThe Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral productionTransport of 9-(2-phosphonomethoxyethyl)adenine across plasma membrane of HeLa S3 cells is protein mediatedMechanism of inhibition of adenovirus DNA replication by the acyclic nucleoside triphosphate analogue (S)-HPMPApp: influence of the adenovirus DNA binding protein.Inhibitory effects of novel nucleoside and nucleotide analogues on Epstein-Barr virus replication.Spectrum of activity and mechanisms of resistance of various nucleoside derivatives against gammaherpesviruses.Adefovir dipivoxil for treatment of breakthrough hepatitis caused by lamivudine-resistant mutants of hepatitis B virus.Factors associated with the virological response of lamivudine-resistant hepatitis B virus during combination therapy with adefovir dipivoxil plus lamivudine.Inhibition of the Synthesis of Proteins Needed for Epstein-Barr Virus Replication by Antisense RNA against the Zta Gene.Efficacy of 9-(2-phosphonylmethoxyethyl)adenine in the therapy of TK+ and TK- herpes simplex virus experimental keratitis.Antiviral Activity Spectrum of Nucleoside and Nucleotide Analogues
P2860
Q28323877-E8723C56-22A4-4F45-9882-622881534B60Q28328542-8C51174D-E397-44AC-B55F-956A0F96CFDCQ28331174-C9076E10-F35C-49CC-9BCD-B29C8F7F9798Q28335579-18DE003A-AD25-402F-AD98-B387B29CA484Q28340298-4530FFF1-44D1-4579-A563-0181956248A2Q28343493-D2FB1D1B-E9C3-4FBB-81B3-9EAF75256B64Q28356469-D906A4DC-5F8D-4EE3-81CA-2FE509A58BBAQ28359881-6FE0ABFE-1E11-4D87-8E31-67C8AC4F9643Q28359995-4EAEC0DD-7E78-49F3-8F72-155945A6969AQ33962669-489F3682-F692-4626-AABB-FB6D5E2D6BBAQ34767204-2BAC0D67-BF76-425F-8F6D-79E80804C3E5Q35119748-714293CA-53BC-4AA8-BB7F-8E7248890BD2Q35941133-E104A1AF-0428-4E4B-B428-ED71C5818B82Q36689248-C9CB820A-449A-4319-9F7A-6F55110C3442Q36757291-5D4AF9A1-34BA-4F59-ACB2-17B4C37A2403Q37123188-323A9D1B-9136-4E7D-9112-7E4E7F3BE8F0Q39351834-60D3AD10-161C-41F7-B7AB-7392A95DE3BDQ39557022-3F498A29-CE02-4221-B2BF-867AFD0C87B6Q39652313-810AE163-AEEF-4CFB-878E-2BB0EB5BFD28Q39735571-D0BA66D3-59E5-41E6-8649-11F16FA80638Q39778904-1C6076F8-8D0F-414D-8E71-94D1F31B2246Q40539014-EB7B823A-0091-4F98-A909-88EF1B4962C7Q40983855-6827D7EA-777E-4285-930C-C79B8980816CQ41722018-76CFE8AD-9D56-442A-BD93-BC0045162E80Q45163318-CD7932BB-C9B4-4862-8806-44BE444338B9Q45403562-1ECD2169-FDCE-41FE-BC6A-851245C13587Q45734634-B5EA8A4C-3A83-4AFB-AF24-2A9C2CEC3B0FQ45863423-D801B945-6F10-4C9D-AAF2-184E42103546Q56786508-8AF5EDA9-6F80-476B-B1A5-7A9EDCED1ACE
P2860
Novel acyclic adenosine analogs inhibit Epstein-Barr virus replication
description
1987 nî lūn-bûn
@nan
1987 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Novel acyclic adenosine analogs inhibit Epstein-Barr virus replication
@ast
Novel acyclic adenosine analogs inhibit Epstein-Barr virus replication
@en
Novel acyclic adenosine analogs inhibit Epstein-Barr virus replication
@nl
type
label
Novel acyclic adenosine analogs inhibit Epstein-Barr virus replication
@ast
Novel acyclic adenosine analogs inhibit Epstein-Barr virus replication
@en
Novel acyclic adenosine analogs inhibit Epstein-Barr virus replication
@nl
prefLabel
Novel acyclic adenosine analogs inhibit Epstein-Barr virus replication
@ast
Novel acyclic adenosine analogs inhibit Epstein-Barr virus replication
@en
Novel acyclic adenosine analogs inhibit Epstein-Barr virus replication
@nl
P2093
P356
P1476
Novel acyclic adenosine analogs inhibit Epstein-Barr virus replication
@en
P2093
P304
P356
10.1128/AAC.31.9.1431
P407
P577
1987-09-01T00:00:00Z